229 related articles for article (PubMed ID: 12458647)
21. Pharmacotherapy for obesity.
Halford JC
Appetite; 2006 Jan; 46(1):6-10. PubMed ID: 16229924
[TBL] [Abstract][Full Text] [Related]
22. [Pharmacological therapy of obesity].
Pagotto U; Vanuzzo D; Vicennati V; Pasquali R
G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
[TBL] [Abstract][Full Text] [Related]
23. Long-term pharmacotherapy for obesity and overweight.
Padwal R; Li SK; Lau DC
Cochrane Database Syst Rev; 2003; (4):CD004094. PubMed ID: 14584004
[TBL] [Abstract][Full Text] [Related]
24. [Overweight patient has tried many times to lose weight. What helps against stubborn fat padding?].
Wirth A
MMW Fortschr Med; 2003 Mar; 145(10):16. PubMed ID: 12688021
[No Abstract] [Full Text] [Related]
25. Sibutramine for obesity in adolescents.
Doggrell SA
Expert Opin Pharmacother; 2006 Dec; 7(17):2435-8. PubMed ID: 17109617
[No Abstract] [Full Text] [Related]
26. Managing obesity like any other chronic condition. Long-term therapy may reduce comorbidity as well.
Agrawal M; Worzniak M; Diamond L
Postgrad Med; 2000 Jul; 108(1):75-6, 79-82. PubMed ID: 10914120
[TBL] [Abstract][Full Text] [Related]
27. New options for drug treatment of obesity in patients with Type 2 diabetes.
Kennedy RL; Khoo EY
Diabet Med; 2005 Sep; 22 Suppl 4():23-6. PubMed ID: 16109016
[No Abstract] [Full Text] [Related]
28. Obesity.
Finer N
Clin Med (Lond); 2003; 3(1):23-7. PubMed ID: 12617409
[No Abstract] [Full Text] [Related]
29. Recent advances in obesity pharmacotherapy.
Mayer MA; Höcht C; Puyó A; Taira CA
Curr Clin Pharmacol; 2009 Jan; 4(1):53-61. PubMed ID: 19149502
[TBL] [Abstract][Full Text] [Related]
30. [Pharmacological treatment for obesity].
Mancillas-Adame L; Morales-González G
Gac Med Mex; 2004; 140 Suppl 2():S91-5. PubMed ID: 15641478
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological treatments for obesity.
McLoughlin C
Prof Nurse; 2005 Apr; 20(8):50-1. PubMed ID: 15819320
[TBL] [Abstract][Full Text] [Related]
32. Clinical pharmacotherapy for obesity: current drugs and those in advanced development.
Halford JC
Curr Drug Targets; 2004 Oct; 5(7):637-46. PubMed ID: 15473253
[TBL] [Abstract][Full Text] [Related]
33. Treating obesity in the family practice setting.
Fernstrom MH
Postgrad Med; 2001 Jun; 109(6 Suppl):10-8. PubMed ID: 19667563
[TBL] [Abstract][Full Text] [Related]
34. [Drug treatment of obesity].
Svendsen OL; Toubro S; Breum L; Bruun JM; Astrup AV
Ugeskr Laeger; 2006 Jan; 168(2):163-7. PubMed ID: 16403342
[TBL] [Abstract][Full Text] [Related]
35. [What effect does losing weight have on hypertension?].
Engeli S
MMW Fortschr Med; 2003 Jul; 145(27-28):44. PubMed ID: 14587188
[No Abstract] [Full Text] [Related]
36. The first decade of sibutramine and orlistat: a reappraisal of their expanding roles in the treatment of obesity and associated conditions.
Coutinho W
Arq Bras Endocrinol Metabol; 2009 Mar; 53(2):262-70. PubMed ID: 19466219
[TBL] [Abstract][Full Text] [Related]
37. [How safe are the new obesity drugs? Indications and contraindications of orlistat and sibutramine].
Richter WO
MMW Fortschr Med; 1999 Dec; 141(49-50):32-6. PubMed ID: 10726144
[TBL] [Abstract][Full Text] [Related]
38. The effects of sibutramine and orlistat on the ultrasonographic findings, insulin resistance and liver enzyme levels in obese patients with non-alcoholic steatohepatitis.
Sabuncu T; Nazligul Y; Karaoglanoglu M; Ucar E; Kilic FB
Rom J Gastroenterol; 2003 Sep; 12(3):189-92. PubMed ID: 14502318
[TBL] [Abstract][Full Text] [Related]
39. [New treatments for obesity].
Féry F; Watrin I
Rev Med Brux; 1999 Sep; 20(4):A381-5. PubMed ID: 10523928
[TBL] [Abstract][Full Text] [Related]
40. [Childhood obesity. Recommendations of the Nutrition Committee of the Spanish Association of Pediatrics. Part II. Diagnosis. Comorbidities. Treatment].
Dalmau Serra J; Alonso Franch M; Gómez López L; Martínez Costa C; Sierra Salinas C
An Pediatr (Barc); 2007 Mar; 66(3):294-304. PubMed ID: 17349257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
